seed
Stage
About
Thestra develops AI-based diagnostic solutions using the proprietary EPLINEX® technology to assess the aggressiveness of head and neck squamous cell carcinoma, enabling precise patient stratification for personalized cancer treatments.
Explore Thestra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.